Related Experiment Video

Updated: May 19, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Medical care costs of newly diagnosed children with structural-metabolic epilepsy: a one year prevalence-based

Muhannad R M Salih1, Mohd Baidi Bahari, Asrul Akmal Shafie

  • 1College of Pharmacy, Al-Rashed University, Baghdad, Iraq. muhanad_rmk@yahoo.com

Seizure
|September 4, 2012
PubMed

Insights

The first-year medical care costs for children with structural-metabolic epilepsy in Malaysia were MYR 202,816. Optimizing seizure control is key to reducing epilepsy management expenses.

Area of Science:

  • Pediatric Neurology
  • Health Economics
  • Epileptology

Background:

  • Epilepsy in children presents a significant healthcare burden.
  • Understanding the economic impact of newly diagnosed epilepsy is crucial for resource allocation.

Purpose of the Study:

  • To estimate the first-year medical care costs for children with structural-metabolic epilepsy.
  • To identify key factors influencing these costs in Malaysia.

Main Methods:

  • Retrospective chart review of pediatric neurology patients in a Malaysian tertiary referral center.
  • Prevalence-based approach with bottom-up microcosting from a provider perspective.
  • Standardized cost data for the year 2010.

Main Results:

  • Total first-year costs were MYR 202,816 (MYR 1690.13 per patient).
  • Antiepileptic drugs were the most significant cost driver, followed by hospitalization and non-antiepileptic drugs.
  • Seizure frequency and antiepileptic drug type significantly predicted costs; demographic and other clinical variables did not.

Conclusions:

  • This is the first cost analysis of childhood epilepsy in Malaysia.
  • Effective seizure control strategies are essential for managing the economic burden of epilepsy.
  • Further research into cost-effective treatment protocols is warranted.
Abstract

More Related Videos

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...